In the context of GLP-1R agonists, GLP-1-expressing NTS neurons project to the VTA [98], and administration of exendin-4 into this brain region reduces food intake [98,99,100] and the motivation to obtain a food reward [99, 100] without causing aversion [98,99,100]
10.1142/9789814447362_0010 701 WilliamsonM
Patient reports of reduced hunger and changed food preferences became increasingly common as the medication gained wider use in endocrinology practices
Resolving controversies on the path to Alzheimers therapeutics
Reducing Body Fat Studies have found that GHRP-2 may support weight loss by stimulating the release of growth hormone (GH), which plays a critical role in fat metabolism
For controlled skin studies, topical application removes the confounders introduced by injection no injection site reactions, no systemic distribution diluting local concentration, no injection technique variability across research subjects